![]() |
市場調查報告書
商品編碼
2130416
動物營養中的生物製劑,全球,2025-2032 年Biotics in Animal Nutrition, Global, 2025-2032 |
||||||
本研究分析了動物飼料、寵物食品和營養補充劑中使用的益生菌、益生元和後生元,重點關注影響腸道健康和生產性能的攝取性生物製劑。本研究範圍不包括非飼料應用(例如青貯飼料接種劑、水產養殖生物修復以及其他環境和加工應用),明確著重於營養功能。本研究面向全球,預測期為2026年至2032年,基準年為2025年。
在最佳化生產力、維護腸道健康和減少抗生素依賴的需求驅動下,動物腸道微生物組成分市場正在快速發展。益生菌和益生元已廣泛應用於畜牧和伴侶動物飼料添加劑領域,而後生元作為新一代解決方案正在崛起,其優勢包括穩定性、一致性和獲得監管部門批准等。這使得後生元成為未來關鍵的創新領域。在寵物領域,重點在於腸道和免疫健康;而在畜牧領域,則利用生物製劑促進生長和減少病原體。
市場成長得益於結構性和需求性因素的共同推動,包括全球飼料和寵物食品產量的擴張、監管政策向無抗生素生產方向的轉變以及對抗菌素抗藥性的擔憂、精準營養和功能性飼料添加劑的日益普及,以及透過差異化解決方案實現的優質化和性價比提升。另一方面,市場也面臨一些短期限制因素,例如供應鏈風險和與西亞衝突相關的成本壓力,這些因素可能會影響規模化生產和獲利能力,尤其是發酵衍生原料。
整體而言,動物營養產業正從依賴投入、成本驅動的體系轉向以增強動物適應能力、提升生產性能為導向的營養模式。在這種模式下,生物製劑在提高飼料轉換率、維護腸道健康和減少抗生素使用方面發揮著至關重要的作用。競爭優勢將越來越依賴發酵技術、產品差異化以及在所有動物種類和生產系統中提供穩定、經科學驗證的性能的能力。
The study analyzes probiotics, prebiotics, and postbiotics used in animal feed, pet food, and supplements, focusing strictly on ingested biotics impacting gut health and performance outcomes. The scope excludes non-feed applications (e.g., silage inoculants, aquaculture bioremediation, and other environmental or processing applications) to maintain a clear focus on nutrition-driven functionality. The research is global, with a forecast period of 2026 to 2032 and a base year of 2025.
The animal gut microbiome ingredients space is evolving rapidly, driven by performance optimization, gut health management, and reduced reliance on antibiotics. Probiotics and prebiotics are well?established feed additives across livestock and companion animals, while postbiotics are emerging as next?generation solutions driven by advantages in stability, consistency, and regulatory acceptance. This positions them as a key future innovation area. Pet use focuses on gut and immune health, while livestock uses biotics to improve growth and reduce pathogens.
Market growth is supported by a combination of structural and demand-side drivers, including expansion of global feed and pet food production, regulatory shift toward antibiotic-free production and antimicrobial resistance concerns, increasing adoption of precision nutrition and functional feed additives, and premiumization and price/value realization through differentiated solutions, among others. At the same time, the market faces short-term constraints such as supply chain risks and cost pressures amid the West Asia war, particularly for fermentation-based inputs, which may impact scalability and margins.
Overall, the animal nutrition industry is transitioning from input-dependent, cost-driven systems toward resilience-driven, performance-oriented nutrition models, where biotics act as critical enablers of feed efficiency, gut health, and antibiotic reduction. Competitive advantage will increasingly depend on fermentation capabilities, product differentiation, and the ability to deliver consistent, scientifically validated performance across species and production systems.